Latest news
Protagonist Therapeutics (PTGX) Swings To Net Income, Is The Valuation Too Expensive? - simplywall.stsimplywall.st · Mon, 10 Aug 2026 02:29:36 GMTProtagonist Therapeutics (PTGX): State Street discloses 5.2% beneficial ownership stake - Stock TitanStock Titan · Fri, 07 Aug 2026 14:46:41 GMTProtagonist Therapeutics: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 20:25:04 GMTProtagonist Therapeutics (NASDAQ: PTGX) jumps on $269.8M 2026 collaboration revenue - Stock TitanStock Titan · Wed, 05 Aug 2026 20:18:01 GMTProtagonist Therapeutics (NASDAQ: PTGX) turns Q2 2026 loss into profit - Stock TitanStock Titan · Wed, 05 Aug 2026 20:12:35 GMTProtagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update - ACCESS NewswireACCESS Newswire · Wed, 05 Aug 2026 20:07:55 GMTProtagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update - News-Press NOWNews-Press NOW · Wed, 05 Aug 2026 20:06:49 GMTTwo New Hires Get Protagonist Stock Awards Vested Over Four Years - Stock TitanStock Titan · Tue, 04 Aug 2026 20:05:00 GMT